Topic: Pediatric cancer.
Destination: Catapult Awards provide funding for Phase 1 or Phase 2 clinical trials that advance promising therapies for pediatric cancer. The Catapult Award uniquely funds cutting-edge clinical trials that begin enrolling patients in less than a year, and every applicant must provide a development plan that demonstrates their ability to move into later-phase clinical trials if successful
Budget: Up to $2,500,000.
Duration: 1-3 years.
Fill out the form below to receive more information: